Integer Holdings (ITGR) Net Income towards Common Stockholders Growth (3y) (2013 - 2025)
Integer Holdings (ITGR) Net Income towards Common Stockholders Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 17.54% |
| 10 | Integer Holdings | 4.26 Bn | 4.24 Bn | 112.94 Mn | -0.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2025 | -26.03% |
| Dec 31, 2024 | -26.27% |
| Sep 27, 2024 | -26.79% |
| Jun 28, 2024 | -89.02% |
| Mar 29, 2024 | -26.07% |
| Dec 31, 2022 | 731.38% |
| Jul 1, 2022 | 61.68% |
| Apr 1, 2022 | 234.29% |
| Dec 31, 2021 | 45.17% |
| Oct 1, 2021 | -51.69% |
| Jul 2, 2021 | 127.03% |
| Apr 2, 2021 | 75.91% |
| Dec 31, 2019 | -26.01% |
| Jun 28, 2019 | 103.30% |
| Mar 29, 2019 | 26.49% |
| Dec 28, 2018 | 28.75% |
| Sep 28, 2018 | 1,972.61% |
| Jun 29, 2018 | -32.51% |
| Mar 30, 2018 | -40.62% |
| Dec 29, 2017 | -77.22% |